The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bickerstaff, A. A.
Right arrow Articles by Orosz, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bickerstaff, A. A.
Right arrow Articles by Orosz, C. G.
The Journal of Immunology, 2000, 164: 5132-5139.
Copyright © 2000 by The American Association of Immunologists

Mechanisms of Graft Acceptance: Evidence That Plasminogen Activator Controls Donor-Reactive Delayed-Type Hypersensitivity Responses in Cardiac Allograft Acceptor Mice1

Alice A. Bickerstaff2,*, Dongyuan Xia*, Ronald P. Pelletier* and Charles G. Orosz*,{dagger},{ddagger}

Departments of * Surgery, {dagger} Pathology, and {ddagger} Molecular Virology, Immunology, and Medical Genetics, and § Comprehensive Cancer Center, Ohio State University College of Medicine, Columbus, OH 43210

We have used delayed-type hypersensitivity (DTH) responses to probe the mechanisms of drug-induced cardiac allograft acceptance in mice. DBA/2->C57BL/6 cardiac allograft recipients treated transiently with gallium nitrate accept their grafts for >90 days and fail to display DBA/2-reactive DTH responses. These DTH responses are restored when anti-TGF-ß Abs are included at the challenge site, and cell depletion studies showed that this DTH inhibition is mediated by CD4+ cells. Real-time PCR analysis revealed that allograft acceptor mice produce no more than background levels of TGF-ß mRNA at DTH challenge sites. This suggests that DTH regulation in allograft acceptor mice may involve TGF-ß activation, rather than TGF-ß production. The protease, plasmin, can activate TGF-ß, and activated T cells can express a receptor for the plasmin-producing enzyme urokinase-type plasminogen activator (uPA), and can also produce both uPA and tissue-type plasminogen activator (tPA). We observed that Abs to tPA or uPA can replace anti-TGF-ß mAb for the restoration of donor-reactive DTH responses in allograft acceptor mice. Histologic analysis revealed that accepted cardiac allografts express uPA, tPA, and active TGF-ß, whereas accepted cardiac isografts express only tPA, but not uPA or activated TGF-ß. These data demonstrate that local tPA and uPA contribute to DTH regulation in allograft acceptor mice and suggest that these elements of the fibrinolytic pathway are used to control donor-reactive cell-mediated immunity in allograft acceptor mice.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Stojakovic, L. I. Salazar-Fontana, Z. Tatari-Calderone, V. P. Badovinac, F. R. Santori, D. Kovalovsky, D. Sant'Angelo, J. T. Harty, and S. Vukmanovic
Adaptable TCR Avidity Thresholds for Negative Selection
J. Immunol., November 15, 2008; 181(10): 6770 - 6778.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. J. T. H. Roelofs, K. M. A. Rouschop, G. J. D. Teske, G. T. M. Wagenaar, N. Claessen, J. J. Weening, T. van der Poll, and S. Florquin
Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection
Nephrol. Dial. Transplant., October 8, 2008; (2008) gfn562v1.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Bogunovic, M. Stojakovic, L. Chen, and M. Maric
An Unexpected Functional Link between Lysosomal Thiol Reductase and Mitochondrial Manganese Superoxide Dismutase
J. Biol. Chem., April 4, 2008; 283(14): 8855 - 8862.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Ilkovitch, M. E. Handel-Fernandez, L. M. Herbert, and D. M. Lopez
Antitumor Effects of Mucin 1/sec Involves the Modulation of Urokinase-Type Plasminogen Activator and Signal Transducer and Activator of Transcription 1 Expression in Tumor Cells
Cancer Res., April 1, 2008; 68(7): 2427 - 2435.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. H. Cook, A. A. Bickerstaff, J.-J. Wang, T. Nadasdy, P. Della Pelle, R. B. Colvin, and C. G. Orosz
Spontaneous Renal Allograft Acceptance Associated with "Regulatory" Dendritic Cells and IDO
J. Immunol., March 1, 2008; 180(5): 3103 - 3112.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K.-H. Sonoda, T. Nakamura, H. A. Young, D. Hart, P. Carmeliet, and J. Stein-Streilein
NKT Cell-Derived Urokinase-Type Plasminogen Activator Promotes Peripheral Tolerance Associated with Eye
J. Immunol., August 15, 2007; 179(4): 2215 - 2222.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Yamaguchi, K. Yamada, T. Suzuki, Y.-P. Wu, K. Kita, S. Takahashi, M. Ichinose, and N. Suzuki
Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP)
Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E970 - E976.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. K. Bishop, S. C. Wood, E. J. Eichwald, and C. G. Orosz
Immunobiology of Allograft Rejection in the Absence of IFN-{{gamma}}: CD8+ Effector Cells Develop Independently of CD4+ Cells and CD40-CD40 Ligand Interactions
J. Immunol., March 1, 2001; 166(5): 3248 - 3255.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.